Penicillin V Potassium
26 NDCs across 5 manufacturers|26 Generic,0 Brand
Penicillin V Potassium is used to treat actinomycosis, anthrax, bacterial infections, botulism, diphtheria and escherichia coli infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product the first generic was approved Jan 1, 1982. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $3 million on Penicillin V Potassium across 467,000 claims for 353,000 beneficiaries.
Penicillin V Potassium is available as 26 NDCs from 5 manufacturers (26 generic, 0 brand), with NADAC prices from $0.06 to $0.15 per EA — the most expensive product costs about 2.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
26
26G / 0B
Manufacturers
5
competing in market
Price Spread
$0.06 – $0.15
per EA, 22 of 26 NDCs
7d Activity
avg -3.1% WoW · of 26 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Penicillin-class Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing PENICILLIN V POTASSIUM(2 pricing outliers)
Frequently Asked Questions
What is Penicillin V Potassium used to treat?
Penicillin V Potassium is used to treat actinomycosis, anthrax, bacterial infections, botulism, diphtheria and escherichia coli infections, per the National Library of Medicine's MED-RT classification.
When did Penicillin V Potassium become available as a generic?
FDA approved the first generic Penicillin V Potassium (ANDA) on Jan 1, 1982. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Penicillin V Potassium?
In 2024, Medicare Part D spent $3 million on Penicillin V Potassium across 467,000 claims for 353,000 beneficiaries.
How many Penicillin V Potassium products are on the market?
The Penicillin V Potassium drug market contains 26 NDCs from 5 manufacturers — 26 generic and 0 brand products.
What is the price range for Penicillin V Potassium?
NADAC reference prices for Penicillin V Potassium range from $0.0608 to $0.1480 per EA — the most expensive product costs about 2.4× the cheapest. 4 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Penicillin V Potassium?
5 manufacturers list Penicillin V Potassium in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (8), Aurobindo Pharma Limited (5), Rising Health, LLC (5), Hikma Pharmaceuticals USA Inc. (4), NorthStar Rx LLC (4).
How has the price of Penicillin V Potassium changed recently?
Over the past 7 days, 11 Penicillin V Potassium NDCs rose and 12 fell, with a market-wide average change of -3.1%.